文献速递神经肿瘤

青少年和青年胶质瘤的独特分子、临床和治疗方面:综述

Unique molecular, clinical, and treatment aspects of gliomas in adolescents and young adults: a review.
PubMed 文献 · J Neurosurg · 2023-05-26

青少年和青年(AYA)胶质瘤患者历史上预后比年轻或年长患者差,差距归因于社会和经济挑战、诊断延迟、临床试验参与度低及缺乏标准化治疗。近期研究修订了世界卫生组织胶质瘤分类,识别出儿童型和成人型肿瘤,两者均可发生于AYA患者,并揭示了靶向治疗机会。本综述聚焦AYA患者关注的胶质瘤类型及多学科团队建设需考虑的因素。

要点

  • AYA胶质瘤患者预后较年轻或年长患者差,与诊断延迟、临床试验参与度低及缺乏标准治疗相关。
  • WHO分类修订识别出儿童型和成人型胶质瘤,两者均可发生于AYA患者。
  • 综述聚焦AYA相关胶质瘤类型及多学科团队建设需考虑的因素。

核心结论

  • AYA胶质瘤患者预后较年轻或年长患者差,与诊断延迟、临床试验参与度低及缺乏标准化治疗相关。
  • 近期研究修订了WHO胶质瘤分类,识别出儿童型和成人型肿瘤,两者均可发生于AYA患者,并揭示了靶向治疗机会。

研究设计与样本

  • 综述,聚焦AYA患者关注的胶质瘤类型及多学科团队建设需考虑的因素。

主要发现

  • AYA胶质瘤患者预后较年轻或年长患者差,差距归因于社会和经济挑战、诊断延迟、临床试验参与度低及缺乏标准化治疗。
  • WHO分类修订识别出生物学上不同的儿童型和成人型胶质瘤,两者均可发生于AYA患者。
  • 近期研究揭示了针对许多AYA胶质瘤患者的靶向治疗机会。

临床怎么用

  • 作者聚焦AYA患者关注的胶质瘤类型及多学科团队建设需考虑的因素,以促进其诊疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Adolescent and young adult (AYA) patients with glioma have historically had poorer outcomes than similar patients of younger or older age, a disparity thought to be attributable to the social and economic challenges faced by this group in the transition from childhood to adult life, delays in diagnosis, low participation of AYA patients in clinical trials, and the lack of standardized treatment approaches specific to this patient group. Recent work from many groups has informed a revision of the World Health Organization classification schema for gliomas to identify biologically divergent pediatric- and adult-type tumors, both types of which may occur in AYA patients, and revealed exciting opportunities for the use of targeted therapies for many of these patients. In this review, the authors focus on the glioma types of specific concern to practitioners caring for AYA patients and the factors that should be considered in the development of multidisciplinary teams to facilitate their care.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lim-Fat MJ, Das S. Unique molecular, clinical, and treatment aspects of gliomas in adolescents and young adults: a review. J Neurosurg. 2023. PMID: 37243561. doi:10.3171/2023.4.JNS221800

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。